메뉴 건너뛰기




Volumn 28, Issue 1, 2012, Pages 3-9

Addressing the controversial use of antipsychotic drugs for behavioral and psychological symptoms of dementia

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ASENAPINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUSPIRONE; CARBAMAZEPINE; CHLORPROMAZINE; CHOLESTEROL; CHOLINESTERASE INHIBITOR; CLOZAPINE; FLUPHENAZINE; GABAPENTIN; HALOPERIDOL; ILOPERIDONE; LURASIDONE; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PLACEBO; PROLACTIN; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TIOTIXENE; TRIACYLGLYCEROL; TRIFLUOPERAZINE; VALPROIC ACID; ZIPRASIDONE;

EID: 84860290668     PISSN: 87551225     EISSN: None     Source Type: Journal    
DOI: 10.1177/875512251202800102     Document Type: Review
Times cited : (2)

References (48)
  • 2
    • 26844538114 scopus 로고    scopus 로고
    • Risk of death with atypical antipsychotic drug treatment for dementia: Meta-analysis of randomized placebo-controlled trials
    • DOI 10.1001/jama.294.15.1934
    • Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005;294:1934-43. (Pubitemid 41464695)
    • (2005) Journal of the American Medical Association , vol.294 , Issue.15 , pp. 1934-1943
    • Schneider, L.S.1    Dagerman, K.S.2    Insel, P.3
  • 3
    • 85038456566 scopus 로고    scopus 로고
    • accessed 2011 Jun 14
    • The Food and Drug Administration. www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm094303.htm (accessed 2011 Jun 14).
  • 4
    • 85038478215 scopus 로고    scopus 로고
    • OIG report evaluates claims for atypical antipsychotic drugs prescribed to nursing home residents
    • Anonymous. May 20, accessed 2011 Jun 14
    • Anonymous. OIG report evaluates claims for atypical antipsychotic drugs prescribed to nursing home residents. Formulary News, May 20, 2011. http://formularyjournal.modernmedicine.com/formulary/articleDetail.jsp?id=7232 (accessed 2011 Jun 14).
    • (2011) Formulary News
  • 5
    • 84860303736 scopus 로고    scopus 로고
    • Government reports wide misuse of antipsychotics
    • Steinke S. Government reports wide misuse of antipsychotics. Caring for the Ages 2011;12:1,8.
    • (2011) Caring for the Ages , vol.12
    • Steinke, S.1
  • 7
    • 33751561455 scopus 로고    scopus 로고
    • Dementia
    • Fausi AS, Kasper DL, Longo DL, et al., eds. 17th ed. New York: McGraw-Hill Medical
    • Bird TD, Miller BL. Dementia. In: Fausi AS, Kasper DL, Longo DL, et al., eds. Harrison's principles of internal medicine. 17th ed. New York: McGraw-Hill Medical, 2008:2536-49.
    • (2008) Harrison's Principles of Internal Medicine , pp. 2536-2549
    • Bird, T.D.1    Miller, B.L.2
  • 8
    • 84860297217 scopus 로고    scopus 로고
    • The ethics of antipsychotics in Alzheimer's
    • Evans J. The ethics of antipsychotics in Alzheimer's. Caring for the Ages 2011;12:27.
    • (2011) Caring for the Ages , vol.12 , pp. 27
    • Evans, J.1
  • 9
    • 33751012402 scopus 로고    scopus 로고
    • Effectiveness of nonpharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: A systematic review
    • DOI 10.1001/archinte.166.20.2182
    • Ayalon L, Gum AM, Feliciano L, Areán PA. Effectiveness of non-pharmacological interventions for the management of neuropsychiatric symptoms in patients with dementia: a systematic review. Arch Intern Med 2006;166:2182-8. (Pubitemid 44748764)
    • (2006) Archives of Internal Medicine , vol.166 , Issue.20 , pp. 2182-2188
    • Ayalon, L.1    Gum, A.M.2    Feliciano, L.3    Arean, P.A.4
  • 10
    • 84860271117 scopus 로고    scopus 로고
    • Music therapy may help dementia patients especially
    • Harrison L. Music therapy may help dementia patients especially. Caring for the Ages 2011;12:1-2.
    • (2011) Caring for the Ages , vol.12 , pp. 1-2
    • Harrison, L.1
  • 12
    • 38949131833 scopus 로고    scopus 로고
    • Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: A literature review
    • DOI 10.1017/S1041610207006540, PII S1041610207006540
    • Konovalov S, Muralee S, Tampi RR. Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review. Int Psychogeriatr 2008;20:293-308. (Pubitemid 351230232)
    • (2008) International Psychogeriatrics , vol.20 , Issue.2 , pp. 293-308
    • Konovalov, S.1    Muralee, S.2    Tampi, R.R.3
  • 13
    • 84860302242 scopus 로고    scopus 로고
    • Alzheimer's disease
    • DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. 8th ed. New York: McGraw-Hill Medical
    • Slattum PW, Swerdlow RH, Hill AM. Alzheimer's disease. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy, a pathophysiologic approach. 8th ed. New York: McGraw-Hill Medical, 2011:958-60.
    • (2011) Pharmacotherapy, A Pathophysiologic Approach , pp. 958-960
    • Slattum, P.W.1    Swerdlow, R.H.2    Hill, A.M.3
  • 14
    • 39749114585 scopus 로고    scopus 로고
    • Management of the behavioral and psychological symptoms of dementia
    • Hersch EC, Falzgraf S. Management of the behavioral and psychological symptoms of dementia. Clin Interv Aging 2007;2:611-21.
    • (2007) Clin Interv Aging , vol.2 , pp. 611-621
    • Hersch, E.C.1    Falzgraf, S.2
  • 15
    • 0035107116 scopus 로고    scopus 로고
    • Recommendations for the management of behavioral and psychological symptoms of dementia
    • Herrmann N. Recommendations for the management of behavioral and psychological symptoms of dementia. Can J Neurol Sci 2001;28(suppl 1):S96-107.
    • (2001) Can J Neurol Sci , vol.28 , Issue.SUPPL. 1
    • Herrmann, N.1
  • 16
    • 0036436448 scopus 로고    scopus 로고
    • Risperidone (Risperdal). Increased rate of cerebrovascular events in dementia trials
    • Wooltorton E. Risperidone (Risperdal). Increased rate of cerebrovascular events in dementia trials. CMAJ 2002;167:11.
    • (2002) CMAJ , vol.167 , pp. 11
    • Wooltorton, E.1
  • 17
    • 0001478989 scopus 로고    scopus 로고
    • Drugs and the treatment of psychiatric disorders
    • Hardman JG, Limbird LE, eds. 10th ed. New York: McGraw Hill Medical
    • Baldessarini RJ, Tarazi FI. Drugs and the treatment of psychiatric disorders. In: Hardman JG, Limbird LE, eds. The pharmacological basis of therapeutics. 10th ed. New York: McGraw Hill Medical, 2001:487-91.
    • (2001) The Pharmacological Basis of Therapeutics , pp. 487-491
    • Baldessarini, R.J.1    Tarazi, F.I.2
  • 18
    • 77956200592 scopus 로고    scopus 로고
    • Drugs for psychotic disorders. Treatment guidelines
    • Anonymous
    • Anonymous. Drugs for psychotic disorders. Treatment guidelines. The Medical Letter 2010;8:61-4.
    • (2010) The Medical Letter , vol.8 , pp. 61-64
  • 19
    • 84863834986 scopus 로고    scopus 로고
    • Movement disorders
    • Tisdale JE, Miller DA, eds. 2nd ed. Bethesda, MD: ASHP
    • Chen JJ, Swope DM. Movement disorders. In: Tisdale JE, Miller DA, eds. Drug induced diseases. 2nd ed. Bethesda, MD: ASHP, 2010:213-8.
    • (2010) Drug Induced Diseases , pp. 213-218
    • Chen, J.J.1    Swope, D.M.2
  • 20
    • 0035286571 scopus 로고    scopus 로고
    • From Clinical Trials to Real-World Practice: Use of Atypical Antipsychotic Medication Nationally in the Department of Veterans Affairs
    • Rosenheck R, Leslie D, Sernyak M. From clinical trials to real-world practice: use of atypical antipsychotic medication nationally in the Department of Veterans Affairs. Med Care 2001;39:302-8. (Pubitemid 33694141)
    • (2001) Medical Care , vol.39 , Issue.3 , pp. 302-308
    • Rosenheck, R.1    Leslie, D.2    Sernyak, M.3
  • 21
    • 3142588866 scopus 로고    scopus 로고
    • Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: Systematic review
    • Lee PE, Gill SS, Freedman M, Bronskill SE, Hillmer MP, Rochon PA. Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia: systematic review. BMJ 2004:329:75-9.
    • (2004) BMJ , vol.329 , pp. 75-79
    • Lee, P.E.1    Gill, S.S.2    Freedman, M.3    Bronskill, S.E.4    Hillmer, M.P.5    Rochon, P.A.6
  • 22
    • 33746884732 scopus 로고    scopus 로고
    • St. Louis, MO. Wolters Kluwer Health
    • Drug facts and comparisons. St. Louis, MO. Wolters Kluwer Health, 2011:933-9.
    • (2011) Drug Facts and Comparisons , pp. 933-939
  • 23
    • 0031756048 scopus 로고    scopus 로고
    • Efficacy and safety of neuroleptics in the behavioral disorders associated with dementia
    • Lanctot KL, Best TS, Mittmann N, et al. Efficacy and safety of neuroleptics in the behavioral disorders associated with dementia. J Clin Psychiatry 1998;59:550-1.
    • (1998) J Clin Psychiatry , vol.59 , pp. 550-551
    • Lanctot, K.L.1    Best, T.S.2    Mittmann, N.3
  • 25
    • 12844274439 scopus 로고    scopus 로고
    • Pharmacological treatment of neuropsychiatric symptoms of dementia: A review of the evidence
    • DOI 10.1001/jama.293.5.596
    • Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA 2005;293:596-608. (Pubitemid 40171242)
    • (2005) Journal of the American Medical Association , vol.293 , Issue.5 , pp. 596-608
    • Sink, K.M.1    Holden, K.F.2    Yaffe, K.3
  • 26
    • 77951761692 scopus 로고    scopus 로고
    • The elderly safety imperative and antipsychotic usage
    • Chahine LM, Acar D, Chemali Z. The elderly safety imperative and antipsychotic usage. Harv Rev Psychiatry 2010;18:158-72.
    • (2010) Harv Rev Psychiatry , vol.18 , pp. 158-172
    • Chahine, L.M.1    Acar, D.2    Chemali, Z.3
  • 27
    • 0032966714 scopus 로고    scopus 로고
    • Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial
    • Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group. J Clin Psychiatry 1999;60:107-15. (Pubitemid 29104387)
    • (1999) Journal of Clinical Psychiatry , vol.60 , Issue.2 , pp. 107-115
    • Katz, I.R.1    Jeste, D.V.2    Mintzer, J.E.3    Clyde, C.4    Napolitano, J.5    Brecher, M.6
  • 30
    • 33644885707 scopus 로고    scopus 로고
    • Risperidone in the treatment of psychosis of Alzheimer's disease: Results from a prospective clinical trial
    • Mintzer J, Greenspan A, Caers I. Risperidone in the treatment of psychosis of Alzheimer's disease: results from a prospective clinical trial. Am J Geriatr Psychiatry 2006;14:280-91.
    • (2006) Am J Geriatr Psychiatry , vol.14 , pp. 280-291
    • Mintzer, J.1    Greenspan, A.2    Caers, I.3
  • 31
    • 0033799993 scopus 로고    scopus 로고
    • Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial
    • Street JS, Clark WS, Gannon KS, et al. Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. Arch Gen Psychiatry 2000;57:968-76.
    • (2000) Arch Gen Psychiatry , vol.57 , pp. 968-976
    • Street, J.S.1    Clark, W.S.2    Gannon, K.S.3
  • 33
    • 23944487151 scopus 로고    scopus 로고
    • Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia
    • Deberdt WG, Dysken MW, Rappaport SA, et al. Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia. Am J Geriatr Psychiatry 2005;13:722-30.
    • (2005) Am J Geriatr Psychiatry , vol.13 , pp. 722-730
    • Deberdt, W.G.1    Dysken, M.W.2    Rappaport, S.A.3
  • 34
    • 25444518037 scopus 로고    scopus 로고
    • Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: A randomized, placebo-controlled study
    • DOI 10.1097/01.jcp.0000178415.22309.8f
    • DeDeyn PP, Jeste DV, Swanink R, et al. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: a randomized, placebo controlled study. J Clin Psychopharmacol 2005;25:463-7. (Pubitemid 41368369)
    • (2005) Journal of Clinical Psychopharmacology , vol.25 , Issue.5 , pp. 463-467
    • De Deyn, P.1    Jeste, D.V.2    Swanink, R.3    Kostic, D.4    Breder, C.5
  • 35
    • 33847132248 scopus 로고    scopus 로고
    • Quetiapine to treat agitation in dementia: A randomized, double-blind, placebo-controlled study
    • DOI 10.2174/156720507779939805
    • Zhong KX, Tariot PN, Mintzer J, Minkwitz MC, Devine NA. Quetiapine to treat agitation in dementia: a randomized double-blind placebo-controlled study. Curr Alzheimer Res 2007;4:81-93. (Pubitemid 46293886)
    • (2007) Current Alzheimer Research , vol.4 , Issue.1 , pp. 81-93
    • Zhong, K.X.1    Tariot, P.N.2    Mintzer, J.3    Minkwitz, M.C.4    Devine, N.A.5
  • 36
    • 47749146154 scopus 로고    scopus 로고
    • Antipsychotics for the treatment of Behavioral and Psychological Symptoms of Dementia (BPSD)
    • DOI 10.2174/157015908784533860
    • Liperoti R, Pedone C, Corsonello A. Antipsychotics for the treatment of behavioral and psychological symptoms of dementia. Curr Neuropharmacol 2008;6:117-24. (Pubitemid 352024796)
    • (2008) Current Neuropharmacology , vol.6 , Issue.2 , pp. 117-124
    • Liperoti, R.1    Pedone, C.2    Corsonello, A.3
  • 39
    • 77956625354 scopus 로고    scopus 로고
    • Swedish clinical guidelines-prevention and management of metabolic risk in patients with severe psychiatric disorders
    • Gothefors D, Adolfsson R, Attvall S, et al. Swedish clinical guidelines-prevention and management of metabolic risk in patients with severe psychiatric disorders. Nord J Psychiatry 2010;64:294-302.
    • (2010) Nord J Psychiatry , vol.64 , pp. 294-302
    • Gothefors, D.1    Adolfsson, R.2    Attvall, S.3
  • 40
    • 56849102843 scopus 로고    scopus 로고
    • Metabolic syndrome and atypical antipsychotics: A selective literature review
    • Kannabrian M, Singh V. Metabolic syndrome and atypical antipsychotics: a selective literature review. German J Psychiatry 2008;11:111-22.
    • (2008) German J Psychiatry , vol.11 , pp. 111-122
    • Kannabrian, M.1    Singh, V.2
  • 41
    • 4644354707 scopus 로고    scopus 로고
    • Atypical antipsychotics and metabolic disregulation: Evaluating the risk/benefit equation and improving the standard of care
    • Nasrallah HA, Newcomer JW. Atypical antipsychotics and metabolic disregulation: evaluating the risk/benefit equation and improving the standard of care. J Clin Psychopharmacol 2004;24(suppl 1):S7-14.
    • (2004) J Clin Psychopharmacol , vol.24 , Issue.SUPPL. 1
    • Nasrallah, H.A.1    Newcomer, J.W.2
  • 43
    • 0036213607 scopus 로고    scopus 로고
    • Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia
    • DOI 10.1176/appi.ajp.159.4.561
    • Sernyak MJ, Leslie DL, Alarcon RD, et al. Association of diabetes mellitus with the use of atypical neuroleptics in the treatment of schizophrenia. Am J Psychiatry 2002;159:561-6. (Pubitemid 34274937)
    • (2002) American Journal of Psychiatry , vol.159 , Issue.4 , pp. 561-566
    • Sernyak, M.J.1    Leslie, D.L.2    Alarcon, R.D.3    Losonczy, M.F.4    Rosenheck, R.5
  • 44
    • 2942618528 scopus 로고    scopus 로고
    • Atypical antipsychotics and risk of cerebrovascular accidents
    • DOI 10.1176/appi.ajp.161.6.1113
    • Herrmann N, Mamdani M, Lanctôt KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004;161:1113-5. (Pubitemid 38736000)
    • (2004) American Journal of Psychiatry , vol.161 , Issue.6 , pp. 1113-1115
    • Herrmann, N.1    Mamdani, M.2    Lanctot, K.L.3
  • 45
    • 77957171407 scopus 로고    scopus 로고
    • Antipsychotic drugs and risk of venous thromboembolism: Nested case-control study
    • Parker C, Coupland C, Hippisley-Cox J. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study. BMJ 2010;341:4245.
    • (2010) BMJ , vol.341 , pp. 4245
    • Parker, C.1    Coupland, C.2    Hippisley-Cox, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.